| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |